Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Individualizing Disease Prevention for Middle-Aged Adults

30. mars 2022 oppdatert av: Glen Taksler
The primary objective of this study is to help patients compare the benefits of various preventive care services, based on their individual risk factors (such as smoking status, obesity, high blood pressure, high cholesterol, etc.). A tailored decision tool will be provided to each participant during primary care appointments to facilitate discussion between the participant and his/her provider regarding prioritizing preventive service recommendations.

Studieoversikt

Status

Avsluttet

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

104

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Ohio
      • Cleveland, Ohio, Forente stater, 44195
        • Cleveland Clinic

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

45 år til 70 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Scheduled for an appointment with primary care provider during study period
  • Two or more of the following risk factors:
  • Tobacco use
  • Overweight/obese
  • Hypertension
  • Hyperlipidemia
  • Diabetes
  • Alcohol Misuse
  • Depression
  • History of Sexually Transmitted Infection
  • Being overdue for the following screenings: Colorectal, cervical, breast, lung

Exclusion Criteria:

- Severely limited life expectancy (cancer, congestive heart failure, chronic obstructive pulmonary disease, end stage renal disease)

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Ingen inngripen: Styre
Vanlig omsorg
Eksperimentell: Intervention
Individualized preventive care recommendations will be distributed to subjects.
Written material provided.
Eksperimentell: Development Phase
Non-randomized receipt of individualized preventive care recommendations
Written material provided.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Interest in Individualized Preventive Care Recommendations.
Tidsramme: Within 3 days of index primary care appointment.

Measured by individualized preventive service recommendations, tailored to patient's specific medical conditions. Measured by surveys.

Survey question: "Overall, how helpful did you find the written materials (handouts)?" Ten point scale (minimum 1, maximum 10, higher score is better outcome)

Within 3 days of index primary care appointment.
Interest in Individualized Preventive Care Recommendations.
Tidsramme: Within 3 days of index primary care appointment.

Measured by individualized preventive service recommendations, tailored to patient's specific medical conditions. Measured by surveys.

Survey question: "In the future, would you like to see updated written materials (handouts)?" Ten point scale (minimum 1, maximum 10, higher score is better outcome)

Within 3 days of index primary care appointment.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Use of Shared Decision Making.
Tidsramme: Within 3 days of index primary care appointment.
Measured by surveys. Survey metric: Shared Decision Making (SDM)-Q-9 validated scale, converted to 100 point denominator 100 point scale (minimum 1, maximum 100, higher score is better outcome)
Within 3 days of index primary care appointment.
Patient Readiness to Change Health Behaviors.
Tidsramme: Within 3 days of index primary care appointment.
Measured by surveys. Proportion of top-3 individualized preventive service recommendations ready to change over next 1 month Numerator: Number of top-3-ranked recommendations with score >=6 out of 7 on Likert scale for readiness to change over next 1 month (minimum=1, maximum=7, higher score was better) Denominator: The number of individualized preventive service recommendations provided to a patient or 3, whichever was lower
Within 3 days of index primary care appointment.
Patient Readiness to Change Health Behaviors
Tidsramme: Within 3 days of index primary care appointment
Measured by surveys Proportion of top-3 individualized preventive service recommendations ready to change over next 2-6 months Numerator: Number of top-3-ranked recommendations with score >=6 out of 7 on Likert scale for readiness to change over next 2-6 months (minimum=1, maximum=7, higher score was better) Denominator: The number of individualized preventive service recommendations provided to a patient or 3, whichever was lower
Within 3 days of index primary care appointment
Patient Readiness to Change Health Behaviors.
Tidsramme: Within 3 days of index primary care appointment
Measured by surveys Proportion of bottom-3 individualized preventive service recommendations ready to change over next 1 month Numerator: Number of bottom-3-ranked recommendations with score >=6 out of 7 on Likert scale for readiness to change over next 1 month (minimum=1, maximum=7, higher score was better) Denominator: The number of individualized preventive service recommendations provided to a patient or 3, whichever was lower
Within 3 days of index primary care appointment
Patient Readiness to Change Health Behaviors
Tidsramme: Within 3 days of index primary care appointment
Measured by surveys. Proportion of bottom-3 individualized preventive service recommendations ready to change over next 2-6 months Numerator: Number of bottom-3-ranked recommendations with score >=6 out of 7 on Likert scale for readiness to change over next 2-6 months (minimum=1, maximum=7, higher score was better) Denominator: The number of individualized preventive service recommendations provided to a patient or 3, whichever was lower
Within 3 days of index primary care appointment
Decisional Comfort.
Tidsramme: Within 3 days of index primary care appointment.
Measured by surveys. Survey metric: Decisional Conflict Scale (validated scale), converted to 100 point denominator 100 point scale (minimum 1, maximum 100, higher score is better outcome)
Within 3 days of index primary care appointment.
Preventive Care Outcomes for Patients.
Tidsramme: Within 1 year of index primary care appointment.
Number of participants with at least 1 follow-up encounter during the 1 year after an index encounter.
Within 1 year of index primary care appointment.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Hovedetterforsker: Glen Taksler, PhD, The Cleveland Clinic

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

22. februar 2017

Primær fullføring (Faktiske)

12. mars 2020

Studiet fullført (Faktiske)

12. mars 2021

Datoer for studieregistrering

Først innsendt

13. januar 2017

Først innsendt som oppfylte QC-kriteriene

13. januar 2017

Først lagt ut (Anslag)

18. januar 2017

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

26. april 2022

Siste oppdatering sendt inn som oppfylte QC-kriteriene

30. mars 2022

Sist bekreftet

1. mars 2022

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 16-854

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere